Search Within

Hospital Medicine

Formats
  1. Meeting Abstract (65)
  2. Journal Article (48)
  3. Book Section (4)
  4. Editorial (3)
  5. Review (3)
  6. Miscellaneous (2)
  7. Research Letter (2)
Groups
  1. General Medicine Services (127)
  2. Department of Medicine (93)
  3. Survivorship Research (63)
  4. Epidemiology and Biostatistics (62)
  5. Biostatistics Service (58)
  6. Hematologic Malignancies, Division of (58)

More Groups

People
  1. Dhwani Patel (44)
  2. Alexander Lesokhin (43)
  3. Carlyn Rose Tan (43)
  4. Hani Hassoun (43)
  5. Malin Hultcrantz (43)
  6. Neha Korde (43)

More People

Years
  1. 2025 (9)
  2. 2024 (11)
  3. 2023 (17)
  4. 2022 (14)
  5. 2021 (12)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Blood (19)
  3. Clinical Lymphoma, Myeloma and Leukemia (11)
  4. Journal of Pain and Symptom Management (6)
  5. Annals of Oncology (3)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Society of Hematology (22)
  3. Elsevier Inc. (20)
  4. Oxford University Press (7)
  5. Springer (7)
  6. American Association for Cancer Research (5)

More Publishers

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Mind the gaps: Building communication bridges during medical codes
    Journal Article

    Chen, L.; Yohannes-Tomicich, J.; McAvoy, E.; Wisely, S.; Buchholz, T.; Atlas, K.; Chawla, S.; Bambrick-Santoyo, G.
    Journal of Interprofessional Education and Practice (2023)

    Fulltext@MSK | Save
  • Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
    Meeting Abstract

    Firestone, R.; Shekarkhand, T.; Patel, D.; Tan, C. R. C.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; Korde, N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Mind the gaps: Building communication bridges during medical codes
    Meeting Abstract

    Chen, L.; Yohannes-Tomicich, J.; Wisely, S.; Buchholz, T.; Mcavoy, E.; Atlas, K.; Chawla, S.; Bambrick-Santoyo, G.
    Critical Care Medicine (2023)

    Fulltext@MSK | Save
  • The Collected Schizophrenias - Narrative insights into schizoaffective disorder
    Miscellaneous

    Hedlin, M.
    JAMA - Journal of the American Medical Association (2023)

    Fulltext@MSK | Save
  • Care at the end of life: Palliative and hospice care—Symptom management
    Book Section

    Goring, T. N.; Nelson, I. L.
    In Sydney, E.; Weinstein, E.; Rucker , L. M. (Eds.) Handbook of Outpatient Medicine. 2nd ed. (2022)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save